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haloperidol (OR 0.74; 95% CI (confidence interval) 0.44, 1.26) was not statistically significantly associated 
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multidisciplinary interventions, as well as collaboration between clinicians on pre- and postoperative care 
practices regarding pharmacological interventions to more effectively reduce and manage POD in older 
people. 
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• An estimated 80% of older people who undergo surgery develop postoperative 
delirium (POD).  
• There is no consensus on appropriate measures for the management of POD. 
• Multidisciplinary approaches show more consistency in the management of POD. 
• Evidence on the use of anti-psychotics and other medications in the management of 









Study objective: An estimated 80% of older people undergoing surgery develop 
postoperative delirium (POD) making them a high-risk group. Research in this area is 
growing fast but there is no established consensus on strategies to for POD prevention or 
management. A systematic review and meta-analysis were conducted to synthesise data on 
clinical interventions used to reduce POD among older people undergoing elective and 
emergency surgery.  
Methods: A range of database searches generated 336 papers. A total of 25 studies met the 
inclusion criteria and were assessed using the Joanna Briggs Institute Critical Appraisal 
Checklist. The studies were undertaken across the world.  
Results: This review identified a range of intervention approaches: comparisons between 
anaesthetic and sedatives agents, medication-specific interventions and multidisciplinary 
models of care. Results found more consistencies across multidisciplinary interventions than 
the pharmacological interventions. In pooled analyses, haloperidol (OR 0.74; 95% CI 
(confidence interval) 0.44, 1.26) was not statistically significantly associated with reduced 
POD incidence any more than a placebo.  
Conclusion: There is a need to implement multidisciplinary interventions, as well as 
collaboration between clinicians on pre- and postoperative care practices regarding 
pharmacological interventions to more effectively reduce and manage POD in older people. 
 
Keywords: Postoperative delirium; pharmacology in older people; meta-analysis; office-








With 80% of older people undergoing surgery developing postoperative delirium (POD) [1], 
they are a high risk group [2]. Delirium is a transient condition that “develops over a short 
period (usually hours to days) and tends to fluctuate during the course of the day and results 
in disturbance of consciousness (i.e. reduced clarity of awareness of the environment) with 
reduced ability to focus, sustain, or shift attention; changes in cognition (e.g., memory deficit, 
disorientation, language disturbance, perceptual disturbance) not accounted for by a pre-
existing, established, or evolving dementia [3]. Its cause is determined from evidence in the 
history taking, physical examination, or laboratory findings that indicate the disturbance is 
caused by a direct physiological consequence of a general medical condition, an intoxicating 
substance, medication use, or more than one cause” [3]. 
Delirium causes poor outcomes, including increased mortality. As the global ageing 
population increases there will be a concomitant increase in POD. The financial burden of 
POD and its associated comorbidities was estimated to be $38 - $150 billion annually in the 
US [4, 5]. The four main risk factors of delirium are being over 65 years and having an acute 
hip fracture, serious illness or pre-existing cognitive impairment [6]. POD incidence ranges 
from 4.0 to 53.3% in individuals undergoing hip fractures and 3.6 to 28.3% in those 
undergoing elective surgery [7]. The pathophysiology of delirium remains poorly understood. 
Its causes are multi-factorial [8, 9] with precipitating factors of anaesthetic or antipsychotic 
medications [8] as well as intraoperative and postoperative blood loss, length of surgery, type 
of surgery, anaesthesia procedure, depth of anaesthesia, pain therapy, fluid management, total 
fasting time, implantation of catheters, and medication use [9]. The  European Society of 







DESC) and recommendation for its prevention [7] but evidence about effective interventions 
to reduce POD remains contradictory. 
 
Specifically, in a survey of anaesthetic nurses and medical anaesthetists from Australia and 
Scotland, 80% reported having a workplace protocol for anaesthetic plans for older people 
but only just over 50% had a workplace protocol to monitor POD [10]. It is imperative that 
there is increased more awareness of POD among older people, as timely detection and 
management of POD is an important step in reducing its incidence and prevalence. 
The aim of this systematic literature review and meta-analysis was to synthesise data on 
pharmacological and non-pharmacological interventions used to reduce POD among older 
people undergoing elective and emergency surgery. The specific objectives were to identify 
medication regimens, including anaesthetics and antipsychotics, non-pharmacological 
interventions and multidisciplinary models of prevention and management that reduce POD 









2 Methods and materials 
 
The literature search for this systematic review was conducted based on recommendations of 
the PRISMA statement [11] (Figure 1). 
 
2.1 Search strategy  
Systematic literature searches of CINAHL, Medline, Web of Science and Cochrane Library 
were conducted to identify studies published in English up to December 2018 on 
interventions aimed at reducing POD among older people. A combination of search terms 
including “delirium prevention”, “anaesthesia,” “surgery”, “older people,” “elderly” and 
“geriatric” were used to search the academic databases (Appendix 1). Two assessors 
reviewed the title and abstracts of publications retrieved from the search to determine which 
publications were to be included and a third assessor was consulted to resolve disparities 
about whether to include a specific publication. 
 
2.2 Selection criteria 
Studies were eligible for inclusion in this review if they met the following criteria according 
to PICOS: 
• Study population participants were aged 65 years and older undergoing a surgical 
procedure requiring anaesthesia; 
• Description of pharmacological and non-pharmacological (including multidisciplinary 
approaches) interventions to reduce POD with a comparator if used; 
• Primary or secondary outcome of studies was incidence/prevalence of POD; 
• Studies that used the prospective quasi-experimental or randomised controlled trial 







• studies published in English. 
 
Studies were excluded from this review if they were cohort studies or duplicated reviews with 
clinical outcomes not POD.  
 
2.3 Data extraction 
Data from each of the published studies included in the systematic review were extracted 
independently by two members of the research team and imported into a table designed 
specifically for this review. Data extracted consisted of study purpose/ aims; design; setting; 
population; intervention/comparator; data collection and analysis; results and conclusions.  
 
2.4 Evaluation of methodological quality 
Full text articles were screened for their relevance and the quality of the studies reported was 
evaluated using the standardised Joanna Briggs Institute (JBI) Critical Appraisal Checklist 
(Tables 2 and Appendix 2) [12]. Three assessors independently screened the publications, 
scored them based on the quality criteria and coded them as ‘include’ when the publication 
met the inclusion criteria. When ratings differed, the assessors discussed the publication to 
reach a consensus about its inclusion in this review. The JBI Checklist is a standardised 
appraisal tool used to evaluate the methodological quality of individual studies in the 
publications and to determine the level to which the possibility of bias was controlled for in 
the design, conduct and analysis of a particular study.  The mean of included studies was 

































During the synthesis stage of the systematic review, a structured approach was adopted to 
identify the key findings across the whole group of studies included in this review [13]. A 
constant comparative method was implemented to identify similar outcomes across the 
Records identified through 
database searching  
























Additional records identified 
through other sources  
(n =9) 
Records after duplicates removed 
(n=321) 
 
Abstracts assessed for 
eligibility  
(n =321) 
Full-text articles excluded; 
studies on delirium but not 
post-operatively and outside 
age range and objectives (n 
= 237)  
Full text assessed 
(n=262) 
Studies included in 
qualitative synthesis  
(n =25) 
Abstracts excluded; 
Review articles (n = 20) 
Studies on children (n= 20) 
RCT protocols (n =10)    
















studies and differences in the outcomes of the interventions evaluated. This method provided 
the framework to present the results for the systematic literature review of interventions used 
to reduce POD among older people undergoing elective and emergency surgery [13]. 
 
2.6 Data analysis on a sub-set of publications included in the review 
The main outcome measure for the data analysis was POD incidence. Publications on 
selected pharmacological interventions were merged and compared statistically in this 
manner. Meta-analysis was carried out on data from four of the RCTs reported in the 
included publications in this review, specifically studies comparing the effects of haloperidol 
interventions versus a control/placebo. A test for heterogeneity was conducted using the chi-
square (χ2) test and the I2 statistic with p<0.10 or I2 >50% considered significant 
heterogeneity. Postoperative delirium incidence (proportion) with 95% CI was calculated 
using the random-effects models in order to account for heterogeneity in participant 
populations and the nature of interventions [14]. We assessed publication bias using funnel 
plots (supplementary material). Meta-analysis was conducted using Cochrane Review 











3.1 Study selection 
The PRISMA flowchart for study selection (Figure 1) summarised the identification, 
screening and inclusion of publications for this systematic review. The initial search 
generated 336 publications. Following title screening and deletion of duplicates, 321 abstracts 
were screened, and 262 full text publications were screened further. After reading the full 
texts, 237 publications were excluded for the following reasons: studies of delirium in 
individuals not undergoing surgery and studies that did not provide POD data. Following this, 
25 studies were included in the final synthesis of this systematic review. A meta-analysis was 
conducted on four (haloperidol interventions) out of the 13 pharmacological intervention 
studies as a result of low numbers in other subgroups.  
 
3.2 Overview 
A broad range of studies were published (n=25) encompassing all clinical settings and all 
types of intervention studies to reduce POD in older people (Table 1): (i) all types of surgery 
specifically, vascular, abdominal and orthopaedic surgery, and (ii) elective and emergency 
surgery. The calculated mean of overall quality of all included studies was 8.7 ± 1.3 (range: 
5-10).  
 
A range of standardised delirium screening tools were used in the studies to detect POD in 
older people (Table 1): the Confusion Assessment Method (CAM)/ CAM-ICU (n=12); the 
Delirium Rating Scale (DRS) (n=3); NEECHAM scale (n=1); and the Organic Brain 








Table 1 Summary of studies included in the systematic literature review 
Study Purpose/aims Research method Setting /Sample and Intervention Data collection & 
analysis 
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Evaluate the effects of the 
delirium-free protocol (DFP) in 
preventing POD after general 








Investigate whether oral 
premedications 
(diphenhydramine and 
diazepam) increased the risk of 




Evaluate the effects of an 
intervention on reducing the 
incidence of POD in older 









Assess the effects of melatonin 
on the incidence of POD in 
older patients following hip 














































Pharmacological intervention: Surgical wards. 
n=42 consecutive patients who underwent resection 
of gastric or colorectal cancer under general 
anaesthesia. 
Intervention: DFP group given intramuscular 
injection of Diazepam at 20:00h each night and a 
continuous intravenous infusion of flunitrazepam 
and pethidine over 8h post-op 
Delivery: (Post) Intramuscular injection 
(0.1mg/kg). 
 
Pharmacological intervention: Elective cardiac 
catheterization patients, n=93. 
Intervention: Patients randomly assigned to 
receive oral premedications (diphenhydramine, 
5mg, and diazepam, 25 mg) vs no oral 
premedication before procedure. 
Delivery: Oral (pre) 5mg. 
 
Non-pharmacological intervention: Orthopaedic 
wards (n=3). n=263 older hip fracture patients: 
intervention (n=131) and control (n=132) 
Intervention: Multi-factorial programs (pre-
hospital and peri-operative management) for 
patients with hip fracture including Supplemental 
oxygen 3–4 l/min and I.V. fluid; extra nutrition; 
higher vitals monitoring; Adequate pain relief; 
avoiding delay in transfers and polypharmacia; 
POD screening and Perioperative/Anaesthetic 
period. 
 
Pharmacological intervention: Patients admitted 
with emergent hip fracture scheduled for surgery 
within 2 days. n=378 patients with hip fracture 
Intervention: patients received a tablet containing 
3mg (± 5%, i.e. 2.85-3.15 mg/tablet) or placebo on 
5 consecutive evenings, starting the day of 
admission. 
 
APACHE II scores. DSM-
IV. 
Unpaired Mann-Whitney 
















OBS Scale scores, DSM 
IV. 
Fisher’s exact test, 
Student’s t-test, Mann-
Whitney and Co- hen’s 
















Incidence of POD 7/20(35%) in non-DFP group and 










Incidence of delirium not reported in either group. Patient 
cooperation and ease of procedure and pain medication 
requirement less during and after the procedure in the pre-





Incidence of delirium significantly reduced during 
hospitalisation from 34 to 22%. Relative risk reduction of 
35% in incidence could be the result of the early 









Treatment with 3 mg of melatonin did not reduce incidence 
of delirium. No observed between group-difference in 




















































Study Purpose/aims Research method Setting /Sample and Intervention Data collection & 
analysis 



















































Evaluate the effects of inpatient 
geriatric consultation teams 
(IGCTs) to reduce incidence of 
POD and cognitive decline in 






implementation of delirium 
friendly pre-printed orders 
(PPOs) by orthopaedic ward 
nurses reduced prevalence of 






Investigate the effects of daily 
post-operative administration of 
low-dose haloperidol on 







Test whether short-term 
administration of oral 
rivastigmine reduces the 
incidence of POD in older 
patients (≥65 yrs) 
 
 




















































Non-pharmacological intervention: Trauma 
wards in a university hospital setting (n=171) 
patients with hip fracture (n=171): intervention 
(n=94) and usual care (n=77). 
Intervention: Clinical assessment: mobilisation, 
follow-up (anti-coagulative, non-opioid pain 
medications and hip x-ray), additional IGCTs 
consultation (post-operatively). 
 
Non-pharmacological intervention: Orthopaedic 
ward (n=283): intervention (n=144) and control 
(n=139). 
Intervention: Usual care PPOs (control) or 
delirium friendly PPOs placed in charts and 
attending physician signed them. Similar PPOs 
except for specific items e.g. urinary catheters 
removed on postoperative day 2 and blood work 
expanded to include electrolytes, urea and creatine 
to help identify dehydration. 
 
Pharmacological intervention: Surgical wards 
(n=121): prophylactic intervention (n=59) and 
control (n=62) patients who underwent elective 
abdominal (under general anaesthesia) or 
orthopaedic surgery (under general/spinal 
anaesthesia). 
Intervention: Low-dose haloperidol (2.5mg/day, 
for first 3 days after surgery). 
Delivery: Intravenously (post) 2.5mg. 
 
Pharmacological intervention: Cardiac surgical 
ward (n=113), intervention (n=56) and control 
(n=57). 
Intervention: three 1.5mg doses per day of 
rivastigmine for 6 days after surgery 






CAM, DI, and MMSE. 
Unpaired t-test Chi-square 







MMSE and CAM. 
Chi-square test for 
categorical variables and t-












Chi-square test for 
comparison and logistic 




MMSE and CAM. 
Chi-square test, Fisher’s 
exact test, t-test or Mann-




The Richmond Agitation 






Geriatric consultation resulted in a 30% lower incidence of 
POD. Delirium episodes during hospitalisation were 
common with hip fracture, but the IGCT reduced the 






Delirium-friendly PPOs implemented regular by nurses led 










Preventive administration of low-dose haloperidol had no 









No observed significant effect of rivastigmine on incidence 






After surgery the melatonin sulphate levels in the nocturnal 
urine was significantly higher (p<0.05) in intervention 



















































Study Purpose/aims Research method Setting /Sample and Intervention Data collection & 
analysis 















































(MNI) on perioperative 
cortisol, melatonin levels and 




Test whether administration of 
risperidone to older patients 
who developed subsyndromal 
delirium (SSD) after cardiac 
surgery reduces the incidence 
of POD (≥65 yrs) 
 
 
Evaluate the effects of a 
geriatric liaison intervention 
compared to effects of standard 
care on the incidence of POD in 






Determine whether Fast-Track 
Surgery (FTS) prevents or 
reduces the incidence of POD 
in older patients and the role of 
IL-6 in POD (≥70 yrs) 
 
 
Evaluate the effects of 1.5mg of 
haloperidol daily vs placebo on 
POD incidence and 
deterioration of POD in hip 





Evaluate the effects of the use 
of haloperidol on reducing 














































Non-pharmacological intervention: Surgical 
ward- oral cancer surgical patients(n=160): 
intervention (n=81) and control (n=79). 
Intervention: multicomponent, non-
pharmacological interventions based on the usual 
care which focused on general geriatric approaches 
and supportive nursing care. 
 
Pharmacological intervention: Surgical ward: 
patient scheduled for on-pump cardiac surgery 
(n=101): intervention (n=51) and placebo (n=50). 
Intervention: 0.5mg of risperidone every 12 hour 
by mouth. 
Delivery: Oral (post) 0.5mg. 
 
 
Non-pharmacological intervention: Surgical 
ward: patients undergoing elective surgery for a 
solid tumour (n=297): intervention (n=148) and 
control (n=149). 
Intervention: multicomponent intervention 
focused on best supportive care and prevention of 
POD - preoperative geriatric consultation as well as 
an individual specific treatment plan targeted at 
delirium risk factors. 
 
Non-pharmacological intervention: Surgical 
ward: patients with colorectal carcinoma admitted 
for open curative resection (n=240): intervention 
(n=120) and control (n=120) 
Intervention: Fast-track peri-operative care 
protocols vs traditional care protocols. 
 
Pharmacological intervention: Surgical and 
orthopaedic wards: patients admitted for acute or 
elective hip surgery (n=430): interventio(n=212) 
and control (n=218). 
Intervention: 1.5mg (0.5mg 3x/day) of 
haloperidol from day of admission to 3 days post-
surgery. 
Delivery: (pre and post) 1.5mg/d. 
 
Pharmacological intervention: Surgical ward: 
patients scheduled for elective gastrointestinal 
Mann-Whitney U test or 
Student’s t-test, Repeated 
measures ANOVA and 
chi-square test. 
 
CAM-ICU, Intensive Care 




Whitney U test, chi-test or 
Fisher’s exact test. 
 
Groningen Fraility 
Indicator (GFI), MMSE, 
Delirium Observation 
Scale (DOS), and DSM-
IV. 
Fisher’s exact test and a 2-
sample Simonov test and 










MMSE, DSM-IV and 
CAM. 
Fisher’s exact test, 
student’s t-test and Mann-










with better RASS scores (p<0.05). Significant reduction 
(p=0.006) in the incidence of POD in the intervention group 




More patients in the placebo group than the intervention 
group experienced delirium (p = 0.031). Administration of 






No observed significant difference in delirium incidence 
between the intervention and control group. The geriatric 








Compared to traditional perioperative management, fast-
track surgery significantly reduced the incidence of POD 
(p=0.008) at least partly attributable to the reduction in 




Low-dose haloperidol prophylactic treatment was not 
effective in reducing the incidence of POD and no effect on 







Incidence of POD was 10.5% (4 of 38 patients) in the 
intervention group compared to 32.5% (13 of 40 patients) in 




















































Study Purpose/aims Research method Setting /Sample and Intervention Data collection & 
analysis 






















































Evaluate the effects of the 
perioperative administration of 
olanzapine on the prevention of 
POD in older patients 
undergoing elective joint 
replacement surgery (≥65 yrs) 
 
 
Evaluate the effects of 
intravenously administered 
dexmedetomidine during 
general anaesthesia on POD in 
older patients with a MCI 
undergoing elective hip joint or 
knee joint or shoulder joint 






Examine the effects of a 
postoperative multi-factorial 
intervention program, including 
comprehensive geriatric 
assessment, management and 
rehabilitation on reducing POD 
in patients undergoing surgery 
for hip fractures (≥70 yrs) 
 
 
Assess the effects of facia iliaca 
compartment block (FICB) for 
prevention of POD in hip 
surgery patients who were at 
intermediate or high risk for 













































surgery received (n=78),: intervention (n=38 and 
control (n=40). 
Intervention: 5 mg of haloperidol intravenously 
postoperatively for 5 consecutive days, or normal 
saline with the same schedule. 




Pharmacological intervention: Surgical ward: 
patients scheduled for elective total knee- or total 
hip-replacement surgery (n=495): intervention 
(n=243) and control (n=252). 
Intervention: 5mg of oral olanzapine or placebo 
just before and after surgery. 
Delivery: Oral (pre and post) 5mg. 
 
Pharmacological intervention: Surgical ward: 
aMCI (n=80) and normal older patients (n=120) 
who underwent a total hip joint or knee joint or 
shoulder joint replacement surgery with general 
anaesthesia. 
Intervention: DEX or normal saline infusion 
during surgery. 
Four groups of aMCI DEX group (n=40), aMCI 
normal saline group (n=40), a control DEX group 
(n=60) and a control normal saline group (n=60) 
Delivery: Infusion (during surgery) 0.2-
0.4µg/kg/h. 
 
Non-pharmacological intervention: Orthopaedic 
department: patients with hip fractures scheduled 
for surgery (n=199): intervention (n=102) and 
control (n=97). 
Intervention: Post-operative care in geriatric ward 
with a special intervention program which involved 
staff education focusing on the detection, 
prevention and management of POD and related 
complications. 
 
Pharmacological intervention: Orthopaedic ward: 
older patients admitted for hip fracture scheduled 
for hip surgery (n=219): FICB prophylaxis (n=108) 








R-98 and CAM. 
Student’s t-test, Wilcoxon 





CDR, MMSE, Montreal 
Cognitive Assessment 
(MoCA) and CAM. 
Pearson chi-square, 
Fisher’s exact test, 
ANOVA and Spearman’s 









15), Organic Brain 
Syndrome (OBS) scale. 
Student’s t-test, chi-square 





MMSE, GDS, DSM-IV 
and CAM. 












Compared to placebo, pre-operative administration of 10mg 
of oral olanzapine resulted in a significantly lower incidence 
of POD (p<0.05), however, POD lasted longer with more 





Positive correlation between age and POD in the aMCI 
normal saline group (p<0.05) but not in the control normal 
saline group. DEX treatment significantly reduced the 
incidence of POD in both control and aMCI groups 









Significantly reduced incidence of POD (p<0.05) and fewer 
days of POD (p<0.05) in the intervention group compared to 








No significant difference in delirium incidence observed in 
high risk patients between FICB prophylaxis and placebo. In 
the intermediate-risk group, FICB prophylaxis significantly 
(p<0.05) prevented delirium occurrence as a result. FICB 




















































Study Purpose/aims Research method Setting /Sample and Intervention Data collection & 
analysis 











































Stenvall et al, 






hydrochloride reduces the 
prevalence and severity of POD 
in older patients undergoing hip 







Compare the effects of 
Propofol and sevoflurane on 
recovery characteristics and the 
incidence of POD in 
laparoscopic surgery (≥65 yrs) 
 
 
Study the influence of 










Determine whether sedation 
depth during spinal anaesthesia 
decreases the prevalence of 






Investigate whether a multi-
disciplinary post-operative 













































Intervention: FICB administration with a 0.25mg 
dose of 0.3mL/kg bupivacaine pre- and 
postoperatively. 
 
Pharmacological intervention: Orthopaedic ward: 
patients admitted for surgical repair of hip fracture 
(n=16): donepezil (n=7) and placebo (n=9). 
Intervention: 5mg capsules of donepezil daily for 
30 days. 






Pharmacological intervention: Elective 
laparoscopic surgical wards (n=2).  n=50 older 
patients: propofol n=25 and sevoflurane n=25). 
Intervention: Propofol used for anaesthesia during 
surgery. Oxygen, epidural analgesia, anaesthesia 
induction and maintenance (intra-operatively). 
 
Pharmacological intervention: Surgical ward: 
patients undergoing primary elective coronary 
artery bypass grafting (CABG) with 
cardiopulmonary bypass (CPB) or single valve 
repair or replacement with CPB (n=70): pregabalin 
(n=35) and placebo (n=35). 
Intervention: 150mg of pregabalin surgery and 
75mg of pregabalin twice daily for 5 post-operative 
days. 
Delivery: Orally, (pre and post) 150mg. 
 
Non-pharmacological intervention: Hip fracture 
surgical wards (n=2).  n=114 older patients: free of 
delirium: deep sedation (n=57) and light sedation 
(n=57). 
Intervention: measurement of sedation depth as 
well as oxygen and I.V fluid. Sedation and 
analgesia: propofol, midazolam and fentanyl (pre- 
and post-operatively). 
 
Non-pharmacological intervention: Orthopaedic 
department at Umea University Hospital (n=1). 
 
MMSE, Delirium 
Symptom Interview (DSI) 
and CAM. 
Chi-square test and 
Wilcoxon rank sum test 
and repeated measure 
time-independent 




Anaesthesia and surgery 
time record, VAS, DRS 
and DSM-III. 
Mann-Whitney U-test, 
Student’s t-test, and 
Fisher’s exact test. 
 
MMSE, RASS and CAM-
ICU. 
Student’s t-test, Fisher’s 
exact test, Mann-Whitney 
















MMSE, OBS and DSM-
IV. 
Student’s t-test, Pearson’s 
Chi-square test, Fisher’s 
 
 
No significant differences in the prevalence or severity of 









Sevoflurane less effective on reducing the occurrence of 
POD compared with propofol for long-duration 
laparoscopic surgery in older patients. Immediate 
emergence i.e. eye opening and extubation was significantly 
faster after sevoflurane (P < 0.05).  
Administration of pregabalin reduced the incidence of 










Use of light propofol sedation reduced the incidence of POD 








Multi-disciplinary program reduced delirium (p = 0.002). 
Significant reduction in number of delirious days (P=0.003) 




















































Study Purpose/aims Research method Setting /Sample and Intervention Data collection & 
analysis 





























infusion of low-dose 
dexmedetomidine decreases 




Evaluate the effects of low-
dose intravenous haloperidol 
for POD prevention in critically 
ill patients after non-cardiac 

















double- blind, RCT 
 
n=64 patients with hip fracture: intervention (n=28) 
and control (n=36). 
Intervention: Staff education, individualised care 
planning and rehabilitation, active prevention, 
detection and management of post-operative 
complications, especially POD. 
 
Pharmacological intervention: ICU: n=700 
patients who underwent elective non-cardiac 
surgery under general anaesthesia, =intervention 
(n=350) and control (n=350). 
Intervention: dexmedetomidine hydrochloride 
200µg/ 2mL. 
Deliver: Intravenous (post), 0.1µg/kg/h. 
 
Pharmacological intervention: ICU in non-
cardiac surgery wards (n=2). n=457 patients: 
intervention (n=229) and placebo (n=228). 
Intervention: Haloperidol 0.5 mg intravenous 
bolus injection followed by continuous infusion at 
a rate of 0.1 mg/h for 12 hours. Analgesia and 
sedation (pre- and post-operatively). 
Delivery:  0.5 mg intravenous bolus injection 
followed by continuous infusion at a rate of 0.1 
mg/h for 12 hrs (post). 
 





CAM-ICU, RASS and 
Numeric Rating Scale 
(NRS). 
Unpaired t-test, Mann-
Whitney U test, chi-square 
test and Kaplan- Meier 
estimator. 
 
Sedation by RASS, 
Delirium by CAM-ICU.   
Student’s t-test or Mann-
Whitney U test and 








Incidence of POD significantly reduced in the 







Administration of low dose intravenous haloperidol 
significantly decreased the incidence of delirium during the 
first 7 post-operative days. Haloperidol significantly delayed 
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Ashraf et al, 2015 [16] 
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Freter et al, 2017 [20] 
 
Fukata et al, 2014 [21] 
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Guo et al, 2016 [23] 
 
Hakim et al, 2012, [24] 
 
Hempenius et al, 2013 [25] 
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Liu et al, 2016 [30] 
 












































































































































































































































































































































































































Question numbers  






1 2 3 4 5 6 7 8 9 10 
 
Marcantonio et al, 2009 [33] 
 
Mouzopoulos et al, 2009 [32] 
 
Nishikawa et al, 2004 [34] 
 
Pesonen et al, 2011 [35] 
 
Sieber et al, 2010 [36] 
 
Stenvall et al, 2012 [37]  
 
Su et al, 2016 [38] 
 





































































































































































































3.3 Intervention description 
The publications included in this review were intervention studies undertaken with older 
people admitted to hospital to undergo surgical procedures. The interventions were classified 
as pharmacological or non-pharmacological and were started pre- or post-operatively 
depending on the nature of intervention. The dosage for pharmacological interventions was 
based on current clinical practice as specified in each individual study. For non-
pharmacological interventions, the duration of intervention was based on usual hospital 
practice. 
 
3.4 Results of individual studies 
The intervention, comparator and results were described for this literature review (Table 1). 
The primary outcome of most of the studies reviewed was the incidence and prevalence of 
POD but for one study it was a secondary objective [35]. Pooled analysis of haloperidol 
interventions showed no significant effect on POD incidence (OR= 0.74, 95%CI = 0.44-
1.26). At the time of this manuscript preparation, the 2014 version of the JBI checklist was 
used to assess methodological quality of included studies. In 2017, the JBI Appraisal 
checklist was updated [40]. 
 
3.4.1 Pharmacological interventions 
There was a total of 16 pharmacological interventions, made up of 3 anaesthetic and sedative 
interventions [32, 34, 35], 13 medication-specific interventions and nine non-
pharmacological, including multidisciplinary interventions. In the pharmacological category, 







medication of choice in four and two studies respectively. A meta-analysis was carried out on 
the haloperidol interventions (Figure 1). 
 
3.4.2 Medication-specific interventions 
A total of 13 publications [15, 16, 18, 21, 22, 24, 27-30, 33, 38, 39] studied the effect of 
medication-specific interventions on POD incidence. In two of the studies [30, 38] 
dexmedetomidine was administered to individuals undergoing non-cardiac surgery and knee, 
hip and shoulder joint surgery respectively. In one study, older people undergoing cardiac 
surgery received a pre-medication dose of diazepam (5mg) or diphenylhydramine (25mg). In 
both groups no POD incidence was recorded [16]. Other medications used were ketamine, 
melatonin, tryptophan and haloperidol for older people undergoing a range of surgeries. In a 
meta-analysis on haloperidol, there was no significant effect observed (OR= 0.74, 95%CI = 
0.44-1.26). No effect was observed on the reduction of POD incidence for hip-fracture [18] 
or orthopaedic and abdominal surgery [21]. 
 
3.4.3 Non-pharmacological interventions 
There was a total of nine non-pharmacological, multidisciplinary interventions. These 
multidisciplinary interventions consisted of continuous monitoring of older people 
undergoing surgery, screening for POD, avoidance of polypharmacy, geriatric consultation 
and nurse-led POD prevention strategies across different surgical wards. Of the nine non-
pharmacological interventions eight showed a significant reduction in POD incidence. Three 
studies designed non-pharmacological interventions, including multidisciplinary trials 
involving geriatric consultation [19, 25, 37]. Results showed a reduction in POD, apart from 







groups. Other non-pharmacological studies with significant results were based on monitoring, 
adequate pain relief, screening and avoidance of polypharmacy in comparison to usual care 
[17], delirium-friendly pre-printed postoperative orders (assessments and continuous 
monitoring) [20], and systematic psychological training and guidance by a geriatrician [23].  
 
Figure 2 Forest plot of effect of haloperidol intervention in four randomized controlled 













This systematic review and meta-analysis summarised the current evidence on the 
effectiveness of pharmacological and non-pharmacological interventions implemented to 
reduce POD. There was more consistency in the results from non-pharmacological 
interventions, including the role of multidisciplinary teams, compared to results from the 
pharmacological interventions where results were contradictory. However, there was no 
consensus on specific non-pharmacological approaches that are more effective in reducing 
the incidence of POD. There is need for more higher quality studies to ensure clinical practice 
can improve detection and management of POD. The inconsistencies observed in results from 
pharmacological interventions could be attributed to differences in methodology as well as 
the possibility that the interventions studied may be ineffective in reducing incidence of POD. 
Another possible explanation could be the different underlying comorbidities in older patients 
which limits generalisation within similar study populations. Research involving older 
individuals usually treat this study population as a homogenous group however, the presence 
of one or more underlying comorbidities presents a significant inter-individual variability in 
this study group [41].  
 
 
4.1 Pharmacologic interventions 
Different pharmacological interventions were trialled in the studies included in this review. 
Some of the medication-specific interventions include: dexmedetomidine, ketamine, 
melatonin, tryptophan and haloperidol.  
 
A recurring theme across studies was pain management as pain post-surgery has been 







appropriate pain control and improved multidisciplinary care practices to ensure patient 
comfort can significantly effect patient outcomes and POD incidence [44]. From this review, 
dexmedetomidine, a novel sedative-analgesic medication, was observed to reduce the 
incidence of POD in older patients [30, 38]. This finding supports previous evidence from a 
meta-analysis that in comparison to other sedatives, dexmedetomidine reduced POD 
incidence [45]. Although the study populations in the dexmedetomidine studies were 
different (one study included patients with mild cognitive impairment (MCI) and the other 
did not), there was agreement in the results from both studies. In the study that included 
patients with MCI [30], a significant correlation was observed between age and POD in older 
people with MCI but not in older people without MCI. Another study [35] observed that 
pregabalin, a medication used to treat neuropathic nerve pain, was effective in reducing POD 
incidence in older people. These studies showed that pain management in clinical practice is 
an important consideration in the prevention of POD.  
 
The use of antipsychotics in the management of POD are too-often the ‘go-to’ solution in 
clinical practice and studies trialling haloperidol to mitigate POD symptoms are common [46, 
47]; all despite clinical guidelines explaining it should be used only in extreme patient 
circumstances because of the severe negative side effects it causes [7, 48-50]. This review 
demonstrated that using haloperidol as an intervention had no significant effect on reducing 
POD which is supported by clinical guidelines. The review evidence presented here was 
sufficiently conclusive to support the cessation of its use in relation to POD in clinical 
practice and trial studies. 
 
Other pharmacological interventions that have been successfully trialled include donepezil 







people with cognitive impairment. Even though donepezil hydrochloride reduces symptoms 
of dementia which has overlapping features with POD [51], studies have shown that this 
medication has no significant effect on POD incidence [32, 52]. There is a possibility that the 
pathophysiology of POD and dementia are different and as a result, donepezil hydrochloride 
which mitigates dementia symptoms has no effect on POD. More in depth research needs to 
be conducted with donepezil hydrochloride in order to determine its efficacy in reducing 
POD incidence. 
 
Conditions related to abnormalities in melatonin metabolism have been associated with 
delirium [53, 54]. One study [18] explored this hypothesis by supplementing older people 
with hip fracture with melatonin for five consecutive days following hospital admission but 
no reduction in POD incidence for older people with hip fracture was observed.  
 
Some studies have indicated that choice of anaesthesia may impact on cognitive status and 
delirium in older patients. However, there is a paucity of evidence on the effects of 
anaesthesia on POD incidence. Two studies included in the current review compared three 
medications. One study [34] compared the effectiveness of propofol-based vs. sevoflurane-
based anaesthesia in relation to onset of POD. From their observation, they concluded that 
sevoflurane was a better option than propofol for general anaesthesia with respect to POD 
incidence. On the other hand, another study [55] compared sevoflurane-based anaesthesia to a 
less common anaesthetic gas, xenon. Their aim was to investigate its feasibility and safety 
due to its limited use in cardiac surgery population groups. Their results showed no 
difference in POD incidence between the two groups. These results show that xenon- and 







relation to POD incidence. More research is required to determine the role of anaesthetic 
medications on POD incidence. 
 
One area that was lacking is the studies included in this review was taking into account the 
home medication of the study populations.  It is therefore not possible to determine whether 
the use of home medications is an important factor to consider when assessing their 
effectiveness for reducing POD. One study on non-pharmacological intervention [17] 
observed that participants in both intervention and control groups treated with anticholinergic 
medications were more likely (p<0.05) to develop POD. The effects of home medications on 
pharmacological interventions used to reduce POD needs to be further studied. 
 
Overall, in relation to pharmacological interventions to reduce POD incidence and prevalence 
in older people undergoing surgery, evidence to-date suggests that appropriate pain 
control/management with, either a sedative or analgesic agent, is the most effective method.  
 
 
4.2 Non-pharmacologic interventions 
Non-pharmacological interventions are often multidisciplinary. Results from the 
multidisciplinary interventions included in this review achieved significant reductions in the 
incidence and prevalence of POD. Education, awareness and multidisciplinary collaboration 
around POD prevention and management was a common non-pharmacologic intervention. 
[17, 19, 20, 23, 26, 31, 36, 37]. Most of these studies resulted in significant reductions in 
POD incidence and prevalence.  Only one of the non-pharmacological intervention studies 
found no significant reduction in POD both in the intervention and control groups [25]. Their 







perhaps a reason why their study did not achieve significant reductions in POD. 
Environmental factors as well as early detection and management, which comes from 
awareness and education of staff, is an important step in reducing POD. There is a possibility 
that the geriatric liaison team did not make a difference as no supplementary delirium care 
education was included in the geriatric liaison team intervention. 
 
Melatonin abnormalities associated with POD onset has also been examined using non-
pharmacological interventions. Guo et. al., [23] found that a multicomponent, non-
pharmacologic intervention improved some postoperative disturbances including sleep and 
stress disorders associated with melatonin metabolism which are major risk factors for POD. 
Guo et. al., [56] determined that in older people who underwent total hip arthroplasty (THA) 
for hip fracture, older age, a history of stroke, lower albumin, higher blood glucose, higher 
total bilirubin, higher C-reactive protein, longer surgery duration and higher volume of red 
blood cell transfusions were independent risk factors for POD. It is important that 
preoperative care of older people includes assessment of these factors at hospital presentation 
to identify those at risk of developing POD and that steps are taken to manage the risk factors 
effectively. 
 
The use of antipsychotics should be managed in accordance with best practice and legislation. 
A meta-analysis of antipsychotic medications for prevention and management of delirium in 
hospitalised adults observed that although there was a heterogeneity in study design and 
population, antipsychotic pharmacotherapy had no significant effect on the prevention or 
management of delirium among adult population groups during a hospital admission [57]. 







improvements on short-term mortality, severity or duration of delirium, and length of ICU 
and hospital stay [57]. 
 
Results from this review show that routine clinical care practices significantly reduced POD 
compared to pharmacological interventions. Studies on medications especially antipsychotics 
showed that the use of these medications did not consistently reduce POD compared to 
placebo. It is imperative that clinical care standards incorporate patient care practices and 
staff education more than new medication protocols in the prevention and management of 
POD. Creating greater understanding about delirium detection, prevention and management 
in clinical settings is the first step in reducing the incidence and prevalence of POD especially 
in the older population. One study explored early detection of delirium by nursing staff in 
order to manage its incidence before onset to decrease adverse events associated with 
delirium [58]. The authors observed that screening for delirium increased awareness of 
nursing staff, indicating the need for more emphasis on early intervention in obvious 
symptoms. 
 
A limitation of this review was the variation in the tools used to diagnose POD in the studies 
reviewed (see results). However, CAM (CAM-ICU), which has been identified as the gold-
standard for POD detection was the commonly used tool or the 4AT a newer tool 
demonstrating its efficacy for delirium screening [59]. This reduced the potential for this 
review to generalise the study outcomes. Another limitation in this meta-analysis was the 
high (60%) heterogeneity conducted on the haloperidol interventions. Heterogeneity might be 







surgery. This emphasises the need to conduct higher quality robust studies using medication-
specific interventions. 
 
In conclusion, there were more consistencies in the non-pharmacological approaches 
included in this review to prevent and manage POD. This could be attributed to the 
heterogeneity across study populations, ineffectiveness of medication-specific interventions 
in reducing POD incidence as well as underlying comorbidities in patients. Pooled analysis of 
haloperidol, an antipsychotic, did not seem to have a significant effect on POD incidence. 
There is need for a general consensus on the most effective way to prevent and manage POD, 
especially among older people where there are higher incidence and prevalence rates. Studies 
included in this review did not take into account the home medication regime of participants. 
A few of the studies recorded the current medications on admission of the participants but 
these were not taken into account in data analysis or any potential clinical effects. In the 
future, this will be an important consideration in the planning aspect of similar studies on 
anticholinergic medication effects. It is also important to explore the impact of studying older 
people with and without preoperative cognitive impairment, dementia or mild and major 
neurocognitive degeneration (NCD) in relation to POD to further understand its progression. 
In addition, understanding the clinical practice around POD and ways to implement protocols 
to screen for delirium in older population groups undergoing surgery is of note in future 
studies. In addition, another important consideration for future research is multidisciplinary 
collaboration between clinicians. This could shed some light on more effective ways to 
reduce POD among older people and subsequently ease the financial burden associated with 
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